Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -132.76M | -138.89M | -124.59M | -118.65M | -89.97M |
| Total Depreciation and Amortization | 18.89M | 19.92M | 19.87M | 23.09M | 19.51M |
| Total Amortization of Deferred Charges | -3.06M | -3.06M | -3.06M | -6.15M | -2.80M |
| Total Other Non-Cash Items | 27.96M | 7.77M | 4.10M | 3.07M | 813.00K |
| Change in Net Operating Assets | -22.29M | -29.20M | -39.78M | -28.36M | -24.83M |
| Cash from Operations | -111.26M | -143.45M | -143.46M | -127.00M | -97.28M |
| Capital Expenditure | -12.63M | -8.36M | -5.05M | -3.70M | -2.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.39M | 278.65M | 280.03M | 280.03M | 280.03M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.74M | 92.88M | 49.35M | 28.96M | 17.73M |
| Cash from Investing | 59.72M | 363.17M | 324.33M | 305.29M | 295.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.00M | -63.19M | -9.44M | -10.28M | -10.28M |
| Issuance of Common Stock | 2.00M | 2.07M | 1.97M | 1.98M | 899.00K |
| Repurchase of Common Stock | -29.93M | -40.95M | -41.08M | -41.42M | -14.06M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -545.00K | -545.00K | -545.00K | -545.00K |
| Cash from Financing | -82.93M | -102.62M | -49.10M | -50.26M | -23.98M |
| Foreign Exchange rate Adjustments | -407.00K | -785.00K | -288.00K | -27.00K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.87M | 116.32M | 131.49M | 128.00M | 173.89M |